MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Luminex Company Profile (NASDAQ:LMNX)

Consensus Ratings for Luminex (NASDAQ:LMNX) (?)
Ratings Breakdown: 1 Sell Rating(s), 5 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $20.17 (4.98% upside)

Analysts' Ratings History for Luminex (NASDAQ:LMNX)
Show:
DateFirmActionRatingPrice TargetActions
5/3/2016Piper JaffrayReiterated RatingHold$19.00 -> $20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/3/2016Leerink SwannReiterated RatingHold$22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/2/2016William BlairReiterated RatingMarket PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/3/2015JPMorgan Chase & Co.Boost Price TargetUnderweight$16.00 -> $18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/3/2015Jefferies GroupBoost Price TargetHold$19.00 -> $21.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/4/2015WedbushUpgradeNeutral -> Outperform$19.00 -> $22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/1/2015Cowen and CompanyBoost Price TargetMarket Perform$17.00 -> $18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/28/2014StephensDowngradeOverweight -> Equal WeightView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/9/2014Citigroup Inc.Initiated CoverageNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/29/2014 forward)
Earnings History for Luminex (NASDAQ:LMNX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/1/2016        
5/2/2016Q116$0.14$0.29$60.98 million$63.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/1/2016Q415$0.15$0.56$60.16 million$60.40 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/2/2015Q315$0.11$0.22$57.24 million$60.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/3/2015Q215$0.11$0.27$57.01 million$58.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/4/2015Q115$0.12$0.23$56.50 million$57.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/2/2015Q414$0.12$0.19$58.31 million$58.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/27/2014Q314$0.10$0.27$56.60 million$56.68 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/28/2014Q214$0.10$0.20$55.90 million$55.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/28/2014Q114$0.12$0.24$55.31 million$56.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/3/2014Q413$0.07$0.21$56.63 million$55.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/4/2013Q313$0.11$0.02$54.67 million$50.80 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/29/2013Q2 2013$0.10$0.17$54.16 million$54.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/29/2013Q1 2013$0.08$0.19$51.94 million$53.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/4/2013Q4 2012$0.08$0.12$54.09 million$55.53 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/29/2012Q312$0.06$0.04$51.26 million$50.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/30/2012$0.08$0.07ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/30/2012$0.09$0.08ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/6/2012$0.07$0.11ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/1/2011$0.05$0.05ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/8/2011$0.06$0.11ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/9/2011$0.06$0.11ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/7/2011$0.05$0.07ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Luminex (NASDAQ:LMNX)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162$0.13$0.14$0.14
Q2 20163$0.14$0.19$0.17
Q3 20163$0.13$0.19$0.15
Q4 20163$0.14$0.18$0.16
(Data provided by Zacks Investment Research)
Dividend History for Luminex (NASDAQ:LMNX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Luminex (NASDAQ:LMNX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
1/4/2016G Walter Loewenbaum IIDirectorSell41,056$20.53$842,879.68View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/31/2015G Walter Loewenbaum IIDirectorSell18,944$21.65$410,137.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/16/2015Russell W. BradleyCMOSell6,514$22.75$148,193.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/28/2015Nachum ShamirCEOBuy6,000$16.73$100,380.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/27/2015G Walter Loewenbaum IIDirectorBuy38,966$16.71$651,121.86View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/5/2015Fred C Goad JrDirectorSell25,000$15.46$386,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/8/2014Russell W BradleySVPSell5,000$20.50$102,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/15/2014Patrick BalthropCEOSell70,000$17.69$1,238,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/12/2014Kevin McnamaraDirectorSell5,000$17.95$89,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/9/2014Jim KeverDirectorSell5,000$17.52$87,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/7/2014Patrick BalthropCEOSell32,575$17.63$574,297.25View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/6/2014Patrick BalthropCEOSell60,000$18.28$1,096,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/2/2014Fred Goad, Jr.DirectorSell50,000$18.86$943,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/2/2014Patrick BalthropCEOSell55,000$19.05$1,047,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/1/2014David ReiterSVPSell15,000$19.09$286,350.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/1/2014Harriss CurrieCFOSell11,000$19.08$209,880.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/23/2013Harriss CurrieCFOSell30,000$19.88$596,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/17/2013Harriss CurrieCFOSell30,000$19.87$596,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/13/2013Michael PintekSVPSell3,000$20.00$60,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/30/2013G Walter Loewenbaum IIDirectorBuy6,034$20.62$124,421.08View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/28/2013G Walter Loewenbaum IIDirectorBuy20,000$20.76$415,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/16/2013Timothy DehneVPSell32,297$20.66$667,256.02View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/15/2013G Walter Loewenbaum IIDirectorBuy10,000$20.82$208,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/14/2013Timothy DehneVPSell1,793$21.21$38,029.53View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/9/2013G Walter Loewenbaum IIDirectorBuy4,600$21.17$97,382.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/2/2013G Walter Loewenbaum IIDirectorBuy27,000$20.01$540,270.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/2/2013Patrick J BalthropCEOSell68,048$20.01$1,361,640.48View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/1/2013David S ReiterSVPSell15,000$20.00$300,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/1/2013Thomas W EricksonDirectorSell20,000$20.00$400,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/24/2013Fred C Goad JrDirectorBuy11,250$18.25$205,312.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/17/2013G Walter Loewenbaum IIDirectorBuy13,000$18.37$238,810.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/16/2013Fred C Goad JrDirectorBuy8,000$18.18$145,440.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/15/2013G Walter Loewenbaum IIDirectorBuy39,500$18.32$723,640.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/10/2013David S ReiterSVPSell10,000$18.26$182,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/10/2013G Walter Loewenbaum IIDirectorBuy19,000$18.13$344,470.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/9/2013G Walter Loewenbaum IIDirectorBuy28,300$17.21$487,043.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/7/2013G Walter Loewenbaum IIDirectorBuy64,935$17.17$1,114,933.95View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/3/2013G Walter Loewenbaum IIDirectorBuy24,765$17.02$421,500.30View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/4/2012David S ReiterVPSell10,000$20.00$200,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Luminex (NASDAQ:LMNX)
DateHeadline
06/21/16 10:31 AMLuminex Corp. – Value Analysis (NASDAQ:LMNX) : June 21, 2016 -
06/20/16 07:30 AMLuminex Corp. breached its 50 day moving average in a Bearish Manner : LMNX-US : June 20, 2016 -
06/02/16 07:47 AMIncreased Earnings Estimates Seen for Luminex (LMNX): Can It Move Higher? -
06/02/16 07:04 AMLuminex's ARIES Flu A/B & RSV Assay Now CE-IVD Marked -
06/02/16 05:25 AMLuminex Corporation Receives CE-IVD Mark for ARIES Flu A/B & RSV Assay - [at noodls] - AUSTIN, Texas, June 1, 2016 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that it has received CE-IVD status under the European Directive on In Vitro Diagnostic Medical Devices for ...
06/02/16 05:00 AMLuminex Corporation Announces Commencement of Tender Offer for All Outstanding Shares of Nanosphere, Inc. Common Stock - [PR Newswire] - AUSTIN, Texas, June 2, 2016 /PRNewswire/ -- Luminex Corporation (LMNX) announced today that its wholly-owned subsidiary Commodore Acquisition, Inc. has commenced its previously announced tender offer to purchase all outstanding shares of common stock of Nanosphere, Inc. (NSPH) for $1.70 per share in cash. The tender offer is being made pursuant to the Agreement and Plan of Merger entered into and among Luminex, Commodore, and Nanosphere dated May 15, 2016 as subsequently amended.
06/01/16 11:57 AMLuminex Gets CE-IVD Mark For ARIES Flu A/B & RSV Assay - Luminex Corporation (NASDAQ: LMNX) disclosed Wednesday that it received CE-IVD status under the European Directive on In Vitro Diagnostic Medical Devices for the ARIES Flu A/B & RSV Assay. The company added that it was meant for use with the FDA cleared and CE-IVD marked ARIES System. The company indicated the ARIES Flu A/B & RSV Assay was a rapid and accurate method for the detection and ...Full story available on Benzinga.com
05/30/16 09:27 AMHC Stock to Path: Nanosphere, Inc. (NASDAQ:NSPH), Eli Lilly and Co (NYSE:LLY) - share market updates (press release) - HC Stock to Path: Nanosphere, Inc. (NASDAQ:NSPH), Eli Lilly and Co (NYSE:LLY)share market updates (press release)On May 23, 2016 – Luminex Corporation (LMNX) and Nanosphere, Inc. (NSPH) announced that they have entered into an amendment to the definitive agreement under which Luminex will acquire Nanosphere, a leader in the molecular microbiology and ...and more »
05/27/16 09:18 AMLuminex Corporation To Present At Jefferies 2016 Healthcare Conference - PR Newswire (press release) - Luminex Corporation To Present At Jefferies 2016 Healthcare ConferencePR Newswire (press release)AUSTIN, Texas, May 26, 2016 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that management will present at the Jefferies 2016 Healthcare Conference to be held June 7-10, 2016, in New York, NY. The investor presentation will ...and more »
05/26/16 03:05 PMLuminex Corporation To Present At Jefferies 2016 Healthcare Conference - [PR Newswire] - AUSTIN, Texas, May 26, 2016 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that management will present at the Jefferies 2016 Healthcare Conference to be held June 7-10, 2016, in New ...
05/23/16 11:03 AMMid-Morning Market Update: Markets Slightly Higher; Arbor Pharmaceuticals to Buy XenoPort For $7.03/Share - Nasdaq - Mid-Morning Market Update: Markets Slightly Higher; Arbor Pharmaceuticals to Buy XenoPort For $7.03/ShareNasdaqNanosphere, Inc. (NASDAQ: NSPH ) shares were also up, gaining 27 percent to $1.66 as Luminex Corporation (NASDAQ: LMNX ) raised its acquisition price for Nanosphere from $1.35 per share to $1.70 per share. The total transaction is now valued about ...and more »
05/23/16 11:03 AMMerger Monday Mania: It's the Market in 5 Minutes - Detroit Free Press - Merger Monday Mania: It's the Market in 5 MinutesDetroit Free PressTribune Publishing (NYSE: TPUB) rejected Gannett's (NYSE: GCI) latest $864 million takeover proposal, but will agree to share confidential information with the U.S. newspaper company. Luminex (NASDAQ: LMNX) and Nanosphere (NASDAQ: NSPH) have ...and more »
05/23/16 11:03 AMLuminex Sweetens Bid To Buy Nanosphere - Benzinga - TheStreet.comLuminex Sweetens Bid To Buy NanosphereBenzingaLuminex Corporation LMNX and Nanosphere, Inc. NSPH have announced an update on Acquisition Agreement. According to the companies, they have struck a definitive agreement under which the former will buy the latter. The Transaction is expected to be ...Luminex Corp. (LMNX), Nanosphere (NSPH) Amend Acquisition Agreement; Price Now at $1.70/ShareStreetInsider.comNanosphere (NSPH) Stock Surging as Luminex Ups BidTheStreet.comAre Nanosphere Shareholders Getting Enough With This New Offer?24/7 Wall St.Mass Device -Sonoran Weekly Reviewall 11 news articles »
05/23/16 09:49 AMNanosphere (NSPH) Stock Surging as Luminex Ups Bid -
05/23/16 09:45 AMAre Nanosphere Shareholders Getting Enough With This New Offer? -
05/23/16 07:43 AMLuminex Sweetens Bid To Buy Nanosphere - Luminex Corporation (NASDAQ: LMNX) and Nanosphere, Inc. (NASDAQ: NSPH) have announced an update on Acquisition Agreement. According to the companies, they have struck a definitive agreement under which the former will buy the latter. The Transaction is expected to be accretive to its adjusted earnings by the end of the next year. Luminex said it has boosted the offer price to $1.70 a share from $1.35 a share in an all cash transaction. The total transaction is now valued about $77 million compared to $58 million at ...Full story available on Benzinga.com
05/23/16 06:43 AMBRIEF-Luminex says, upon termination of merger agreement, Nanosphere would have to pay termination fee of $2.25 mln - * Upon termination of merger agreement, under specified circumstances, Nanosphere would have been required to pay co termination fee of $2.25 million
05/23/16 05:26 AMLUMINEX CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Stat -
05/20/16 09:41 AMRevenue Update on Luminex Corporation(NASDAQ:LMNX) - Trade Calls - Revenue Update on Luminex Corporation(NASDAQ:LMNX)Trade CallsLuminex Corporation(NASDAQ:LMNX) announced the earnings results for Fiscal Year 2016 and Q1. The results came in during After-hours on May 2, 2016. Company reported revenue of $62.98M. Analysts estimated a revenue of $60.98M. Earnings per ...Luminex Corporation (NASDAQ:LMNX) Shorted Shares Decreased By 2.49%The PostAre Analysts Bullish Luminex Corporation (NASDAQ:LMNX) After Last Week?Franklin IndependentAnalyst Recommendations On Luminex Corporation (NASDAQ:LMNX)News Tribuneall 5 news articles »
05/18/16 09:38 PMETF’s with exposure to Luminex Corp. : May 19, 2016 -
05/18/16 08:47 AMRodman & Renshaw Downgrades Nanosphere Following Luminex Acquisition - Rodman & Renshaw's Raghuram Selvaraju downgraded Nanosphere, Inc. (NASDAQ: NSPH) from Buy to Neutral, while decreasing the price target from $2.00 to $1.35. The rating change came after Luminex Corporation (NASDAQ: LMNX) announced it was acquiring Nanosphere for $1.35 a share in an all-cash transaction. Related Link: Here's Why Wells Fargo Doesn't Like Valeant's Big Bonuses Luminex plans to purchase ...Full story available on Benzinga.com
05/17/16 07:22 AMLuminex Corp. breached its 50 day moving average in a Bullish Manner : LMNX-US : May 17, 2016 -
05/17/16 07:02 AMLuminex (LMNX) to Buy Nanosphere, Eyes Portfolio Expansion -
05/16/16 05:43 PMNotable Mergers and Acquisitions 5/16: (PFE)/(ANAC) (RRC)/(MRD) (LMNX)/(NSPH) (LECO) (EQIX)/(DLR) - Morgan Stanley & Co LLC and Barclays Capital Inc. acted as financial advisors ... "The acquisition of Nanosphere will significantly enhance Luminex's growth trajectory by expanding our product portfolio, delivering access to new markets and strengthening ...
05/16/16 03:05 PMLuminex to Highlight Latest Additions to Product Portfolio at the 2016 Clinical Virology Symposium - [PR Newswire] - AUSTIN, Texas, May 16, 2016 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced it will highlight the latest additions to its product portfolio at the 32 nd Annual Clinical Virology Symposium, ...
05/16/16 02:40 PMLuminex looks to acquire Illinois biotech firm for $58M -
05/16/16 12:33 PMMid-Day Market Update: Nanosphere Jumps Following Luminex Deal; Breitburn Energy Partners Shares Drop - Midway through trading Monday, the Dow traded up 0.64 percent to 17,647.80 while the NASDAQ surged 0.81 percent to 4,756.09. The S&P also rose, gaining 0.63 percent to 2,059.54. Leading and Lagging Sectors Basic materials shares rose around 2.02 percent in trading on Monday. Top gainers in the sector included Bill Barrett Corporation (NYSE: BBG), Newpark Resources Inc (NYSE: NR), and Approach Resources Inc. (NASDAQ: AREX). In trading on Monday, utilities shares slipped by 0.1 percent. Meanwhile, top losers in the sector included Companhia Paranaense de Energia (ADR) (NYSE: ELP), down 3 percent, and TransAlta Corporation (USA) (NYSE: TAC), down 2 percent. Top Headline Pfizer Inc. (NYSE: PFE) announced plans to buy Anacor Pharmaceuticals Inc (NASDAQ: ANAC) for $99.25 per share in cash. The total transaction value, net of ...Full story available on Benzinga.com
05/16/16 11:05 AMLuminex Corp. (LMNX) to Acquire Nanosphere (NSPH) for $1.35/Share - StreetInsider.com - Washington TimesLuminex Corp. (LMNX) to Acquire Nanosphere (NSPH) for $1.35/ShareStreetInsider.comLuminex Corporation (NASDAQ: LMNX) and Nanosphere, Inc. (NASDAQ: NSPH) today announced that the companies have entered into a definitive agreement under which Luminex will acquire Nanosphere, a leader in the molecular microbiology and ...Mid-Morning Market Update: Markets Open Higehr; Pfizer To Acquire Anacor Pharmaceuticals For $5.2BBenzingaall 84 news articles »
05/16/16 10:03 AMSHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation Concerning the Fairness of the Sale of Nanosphere, Inc. to Luminex Corporation for $1.35 Per Share - NSPH - [Accesswire] - NEW YORK, NY / ACCESSWIRE / May 16, 2016 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Nanosphere, Inc.(NASDAQ: NSPH) stock prior to May ...
05/16/16 09:48 AMNanosphere (NSPH) Stock Skyrockets on $58 Million Luminex Deal -
05/16/16 07:25 AMLuminex Agrees To Buy Nanosphere For $58 Million - Luminex Corporation (NASDAQ: LMNX) and Nanosphere, Inc. (NASDAQ: NSPH) have signed a definitive agreement. Accordingly, the former will acquire the latter, a leader in the molecular microbiology and molecular diagnostic market, for $1.35 per share in an all cash transaction. The deal is worth about $58 million, which would be funded from its cash on hand. The offer price carried a premium of 73 percent compared to the Friday's closing price. The companies indicated that the transaction could close in the second quarter. As per the terms of the agreement, Luminex's payment included outstanding common stock, preferred stock, and options and warrants of Nanosphere. ...Full story available on Benzinga.com
05/16/16 06:21 AMBRIEF-Nanosphere to pay Luminex fee of $2.25 mln upon termination of merger - SEC filing - * Upon termination of merger agreement, company will be required to pay luminex a termination fee of $2.25 million - sec filing
05/16/16 06:14 AMLUMINEX CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, Other Events, -
05/16/16 05:57 AMLuminex buys Nanosphere for $58M -
05/16/16 05:22 AMLuminex Corporation Signs Definitive Agreement to Acquire Nanosphere, Inc. - [at noodls] - AUSTIN, Texas and NORTHBROOK, Ill., May 16, 2016 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) and Nanosphere, Inc. (NASDAQ: NSPH) today announced that the companies have entered into a definitive ...
05/07/16 12:04 PMLUMINEX CORP Financials -
05/05/16 04:33 PMETF’s with exposure to Luminex Corp. : May 5, 2016 -
05/05/16 11:22 AMLuminex Corp. :LMNX-US: Earnings Analysis: Q1, 2016 By the Numbers -
05/05/16 08:24 AMLuminex (LMNX) Beats Q1 Earnings & Revenues, Guides Up -
05/04/16 07:47 AMLuminex Corp. breached its 50 day moving average in a Bearish Manner : LMNX-US : May 4, 2016 -
05/03/16 10:26 AMLUMINEX CORP Files SEC form 10-Q, Quarterly Report -
05/03/16 12:14 AMEdited Transcript of LMNX earnings conference call or presentation 2-May-16 8:30pm GMT -
05/02/16 04:15 PMLuminex posts 1Q profit -
05/02/16 03:30 PMLuminex Corp Earnings Call scheduled for 4:30 pm ET today -
05/02/16 03:13 PMLUMINEX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Change in Directors or Principal Offi -
05/02/16 03:05 PMLuminex Corporation Reports First Quarter 2016 Results - [PR Newswire] - AUSTIN, Texas, May 2, 2016 /PRNewswire/ -- Luminex Corporation (NASDAQ:LMNX) today announced financial results for the first quarter ended March 31, 2016. Financial and operating highlights for the first ...
05/02/16 06:07 AMQ1 2016 Luminex Corp Earnings Release - After Market Close -
04/28/16 06:41 PMVillere St Denis J & Co LLC Lowers Its Holdings in Luminex Corporation (LMNX) Stock Last Quarter - Villere St Denis J & Co LLC reports that it lowered its investment in Luminex Corporation by 10.3% in the last quarter. Its investment was valued at $91,427,000 a decrease of $21,004,000 as of quarter end. Here are some other firms who have updated their ...
04/28/16 07:30 AMLuminex Corporation To Present At Investment Conferences In May - [PR Newswire] - AUSTIN, Texas, April 28, 2016 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) announced today that management will present at two upcoming investment conferences in May: The Bank of America Merrill ...
04/19/16 11:59 PMWith Shares Trading up at $53.00 ( DOW ) AIChE Foundation Announces Co-Chairs For… - Shares now down at $66.80 ( DXCM ) Dexcom, Inc. Issues Press Release To... Stock is down at $19.35 ( LMNX ) Luminex Corporation First Quarter... Shares now up at $4.54 MobileIron Access: bedrijfsgegevens in... With Shares Trading up at $31.11 ( GT ...
About Luminex

Luminex logoLuminex Corporation develops, manufactures and sells biological testing technologies with applications throughout the diagnostics, pharmaceutical and life sciences industries. The Company has a range of instruments using its xMAP technology, including its LUMINEX 100/200 systems offer 100-plex testing; the Company's FLEXMAP 3D system is its high-throughput, 500-plex testing system, and its MAGPIX system provides 50-plex testing using imaging rather than flow cytometry. By using its xMAP technology, the end users are able to generate multiple simultaneous results per sample. The Company primarily serves the diagnostics, pharmaceutical and life sciences industries by marketing products, including its testing equipment and assays, to various types of testing laboratories. The Company's assay products are focused on three segments of the molecular diagnostic testing market: human genetics, personalized medicine and infectious disease.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Instruments & Supplies
  • Sub-Industry: Life Sciences Tools & Services
  • Exchange: NASDAQ
  • Symbol: LMNX
  • CUSIP: 55027E10
Key Metrics:
  • Previous Close: $19.21
  • 50 Day Moving Average: $20.10
  • 200 Day Moving Average: $19.77
  • P/E Ratio: 21.58
  • P/E Growth: 0.50
  • Market Cap: $832.56M
  • Current Quarter EPS Consensus Estimate: $0.67 EPS
Additional Links:
Luminex (NASDAQ:LMNX) Chart for Wednesday, June, 29, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha